Abdelaziz Toumi Appointed CEO of Lupin's New API CDMO Subsidiary

Lupin Limited has announced Abdelaziz Toumi as the CEO of its new subsidiary, Lupin Manufacturing Solutions (LMS), dedicated to Active Pharmaceutical Ingredients (API) and Contract Development and Manufacturing Operations (CDMO).

Abdelaziz Toumi, often called Abdel, brings over twenty years of experience from his previous leadership roles in reputable companies such as Bayer and Merck. Positioned to lead LMS from Switzerland, Abdel will also frequently work out of India, aiming to position LMS as a global leader in the API CDMO sector. His appointment underscores Lupin's commitment to expanding its operations and enhancing service delivery across global markets.